Pharmala Biotech Holdings Inc C.MDMA

Chart

[inviolablspirit]

The chart continues to look good and is ready for another move up on a good news release.  A solid base is being formed.  I like the "W" formation running along this newly established base.  The stock tested 28 cents for a closing low price twice.  A nice double bottom.  

2025 should be a good year for Pharmala once it is noticed in the US or by larger investors around the world. The trading is still very quiet outside the Canadian exchanges. Sooner or later one would think investors, hedge funds and institutions may be interested in who is supplying nearly all the MDMA world wide.  Key price points Pharmala needs to get past, 50 cents, $1 and $2.

[inviolablspirit]

I noticed the last few trading sessions the volume has picked up on the US exchanges.  The push down looks to be coming from there.  

[inviolablspirit]

Instinet looks to be the culprit as they only recently showed up.  They execute trade for assest managment groups.  I would think they have been using anonymous on the dumps to put the shares in the hands of groups like Dejardins.  That would be my guess.

[inviolablspirit]

On the technical side, the RSI is now down to where it was when Pharmala was at 8.5 cents.  This gives the stock plenty of upside.  Money flow is also at the same level too.  Although I didn't like to see the double bottom at 28 cents get broken, we'll see what happens at 26 cents.  Too much positive news on the horizon to hold this stock down for long.  I'm

[inviolablspirit]

I noticed a couple of weeks ago as did another guy on CEO just recently mentioned it, that the outstanding shares in the company has decreased according to stockhouse and according to the platform that I use to trade.  However, it still reads 95.94 on CEO.  Anyone else's platform list the outstanding shares somewhere between 91.124  and 91.72 million?   Both stockhouse and